Jun Zou, Ph.D. - Related publications

Affiliations: 
2005 University of Missouri - Columbia, Columbia, MO, United States 
Area:
Biochemistry, Molecular Biology
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Abbasi Gharibkandi N, Conlon JM, Hosseinimehr SJ. Strategies for improving stability and pharmacokinetic characteristics of radiolabeled peptides for imaging and therapy. Peptides. 133: 170385. PMID 32822772 DOI: 10.1016/j.peptides.2020.170385   
2020 Hilchie AL, Gill EE, Coombs MRP, Falsafi R, Hancock REW, Hoskin DW. MDA-MB-231 Breast Cancer Cells Resistant to Pleurocidin-Family Lytic Peptides Are Chemosensitive and Exhibit Reduced Tumor-Forming Capacity. Biomolecules. 10. PMID 32842611 DOI: 10.3390/biom10091220   
2020 Wang X, Zheng Y, Bao C, Zhong G, Liu S, Wiradharma N, Fan W, Yang YY, Wang X, Huang Y. Branched α-helical peptides enhanced antitumor efficacy and selectivity. Biomaterials Science. PMID 33029595 DOI: 10.1039/d0bm00629g   
2020 Descalzi-Montoya D, Montel RA, Smith K, Dziopa E, Darwich A, Yang Z, Bitsaktsis C, Korngold R, Sabatino D. Synthetic Antibody Mimics Based on Cancer-Targeting Immunostimulatory Peptides. Chembiochem : a European Journal of Chemical Biology. PMID 32964656 DOI: 10.1002/cbic.202000407   
2020 Wu W, Chen Y, Huang L, Li W, Tao C, Shen H. Point mutation screening of tumor neoantigens and peptide-induced specific cytotoxic T lymphocytes using The Cancer Genome Atlas database. Oncology Letters. 20: 123. PMID 32934692 DOI: 10.3892/ol.2020.11986   
2020 Li C, Li J, Xu Y, Zhan Y, Li Y, Song T, Zheng J, Yang H. Application of Phage-Displayed Peptides in Tumor Imaging Diagnosis and Targeting Therapy. International Journal of Peptide Research and Therapeutics. 1-9. PMID 32901205 DOI: 10.1007/s10989-020-10108-5   
2020 Daso RE, Banerjee IA. Self-Assembled Peptide Based Biocomposites for Near Infra-red Light Triggered Drug Release to Tumor Cells. Biotechnology Journal. e2000128. PMID 32845561 DOI: 10.1002/biot.202000128   
2020 Judmann B, Braun D, Wängler B, Schirrmacher R, Fricker G, Wängler C. Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy. Pharmaceuticals (Basel, Switzerland). 13. PMID 32751666 DOI: 10.3390/ph13080173   
2020 Benfield AH, Defaus S, Lawrence N, Chaousis S, Condon N, Cheneval O, Huang YH, Chan LY, Andreu D, Craik DJ, Henriques ST. Cyclic gomesin, a stable redesigned spider peptide able to enter cancer cells. Biochimica Et Biophysica Acta. Biomembranes. 183480. PMID 32979382 DOI: 10.1016/j.bbamem.2020.183480   
2020 Yaghoubi A, Khazaei M, Avan A, Hasanian SM, Cho WC, Soleimanpour S. p28 Bacterial Peptide, as an Anticancer Agent. Frontiers in Oncology. 10: 1303. PMID 32850408 DOI: 10.3389/fonc.2020.01303   
2020 Luo X, Teng QX, Dong JY, Yang DH, Wang M, Dessie W, Qin JJ, Lei ZN, Wang JQ, Qin Z, Chen ZS. Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance. Frontiers in Pharmacology. 11: 1208. PMID 32903706 DOI: 10.3389/fphar.2020.01208   
2020 Huang C, Dai XY, Cai JX, Chen J, Wang BB, Zhu W, Wang E, Wei W, Zhang JV. A Screened GPR1 Peptide Exerts Antitumor Effects on Triple-Negative Breast Cancer. Molecular Therapy Oncolytics. 18: 602-612. PMID 33005727 DOI: 10.1016/j.omto.2020.08.013   
2020 Smalley H, Rowe JM, Nieto F, Zeledon J, Pollard K, Tomich JM, Fleming SD. Beta2 glycoprotein I-derived therapeutic peptides induce sFlt-1 secretion to reduce melanoma vascularity and growth. Cancer Letters. PMID 32891714 DOI: 10.1016/j.canlet.2020.08.039   
2020 Cheng B, Xu P. Redox-Sensitive Nanocomplex for Targeted Delivery of Melittin. Toxins. 12. PMID 32927695 DOI: 10.3390/toxins12090582   
2020 Morais CM, Cardoso AM, Aguiar L, Vale N, Nóbrega C, Zuzarte M, Gomes P, Pedroso de Lima MC, Jurado AS. Lauroylated Histidine-Enriched S4-PV Peptide as an Efficient Gene Silencing Mediator in Cancer Cells. Pharmaceutical Research. 37: 188. PMID 32888084 DOI: 10.1007/s11095-020-02904-x   
2020 Yadav PK, Gupta SK, Kumar S, Ghosh M, Yadav BS, Kumar D, Kumar A, Saini M, Kataria M. MMP-7 derived peptides with MHC class-I binding motifs from canine mammary tumor tissue elicit strong antigen-specific T-cell responses in BALB/c mice. Molecular and Cellular Biochemistry. PMID 32970284 DOI: 10.1007/s11010-020-03908-2   
2020 Zhu L, Ding Z, Li X, Wei H, Chen Y. Research Progress of Radiolabeled Asn-Gly-Arg (NGR) Peptides for Imaging and Therapy. Molecular Imaging. 19: 1536012120934957. PMID 32862776 DOI: 10.1177/1536012120934957   
2020 Wang Y, Song EC, Resnick MB. Elastin in the Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1272: 1-16. PMID 32845499 DOI: 10.1007/978-3-030-48457-6_1   
2020 Yasuda T, Nishiki K, Hiraki Y, Kato H, Iwama M, Shiraishi O, Yasuda A, Shinkai M, Kimura Y, Sukegawa Y, Chiba Y, Imano M, Takeda K, Satou T, Shiozaki H, et al. Phase II Adjuvant Cancer-specific Vaccine Therapy for Esophageal Cancer Patients Curatively Resected After Preoperative Therapy With Pathologically Positive Nodes; Possible Significance of Tumor Immune Microenvironment in its Clinical Effects. Annals of Surgery. PMID 33055588 DOI: 10.1097/SLA.0000000000003880   
2020 Rapalli VK, Waghule T, Gorantla S, Dubey SK, Saha RN, Singhvi G. Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems. Drug Discovery Today. PMID 33011340 DOI: 10.1016/j.drudis.2020.09.023   
2020 Hedegaard CL, Redondo-Gómez C, Tan BY, Ng KW, Loessner D, Mata A. Peptide-protein coassembling matrices as a biomimetic 3D model of ovarian cancer. Science Advances. 6. PMID 33008910 DOI: 10.1126/sciadv.abb3298   
2020 Wells DK, van Buuren MM, Dang KK, Hubbard-Lucey VM, Sheehan KCF, Campbell KM, Lamb A, Ward JP, Sidney J, Blazquez AB, Rech AJ, Zaretsky JM, Comin-Anduix B, Ng AHC, Chour W, ... , et al. Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction. Cell. PMID 33038342 DOI: 10.1016/j.cell.2020.09.015   
2020 Trac N, Chen LY, Zhang A, Liao CP, Poon C, Wang J, Ando Y, Joo J, Garri C, Shen K, Kani K, Gross ME, Chung EJ. CCR2-targeted micelles for anti-cancer peptide delivery and immune stimulation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33011241 DOI: 10.1016/j.jconrel.2020.09.054   
2020 Gu W, Meng F, Haag R, Zhong Z. Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33022328 DOI: 10.1016/j.jconrel.2020.10.003   
2020 Weis-Banke SE, Hübbe ML, Holmström MO, Jørgensen MA, Bendtsen SK, Martinenaite E, Carretta M, Svane IM, Ødum N, Pedersen AW, Met Ö, Madsen DH, Andersen MH. The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines. Oncoimmunology. 9: 1771142. PMID 32923127 DOI: 10.1080/2162402X.2020.1771142   
2020 Weis-Banke SE, Hübbe ML, Holmström MO, Jørgensen MA, Bendtsen SK, Martinenaite E, Carretta M, Svane IM, Ødum N, Pedersen AW, Met Ö, Madsen DH, Andersen MH. The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines. Oncoimmunology. 9: 1771142. PMID 32923127 DOI: 10.1080/2162402X.2020.1771142   
2020 Holmes TR, Al-Matouq J, Holmes M, Nicola L, Rudd JC, Lovas S, Hansen LA. Targeting 14-3-3ε-CDC25A interactions to trigger apoptotic cell death in skin cancer. Oncotarget. 11: 3267-3278. PMID 32934772 DOI: 10.18632/oncotarget.27700   
2020 Mirando AC, Patil A, Rafie CI, Christmas BJ, Pandey NB, Stearns V, Jaffee EM, Roussos Torres ET, Popel AS. Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide. Oncoimmunology. 9: 1760685. PMID 32923118 DOI: 10.1080/2162402X.2020.1760685   
2020 Permpoon U, Khan F, Vadevoo SMP, Gurung S, Gunassekaran GR, Kim MJ, Kim SH, Thuwajit P, Lee B. Inhibition of Tumor Growth against Chemoresistant Cholangiocarcinoma by a Pro-apoptotic Peptide Targeting Interleukin-4 Receptor. Molecular Pharmaceutics. PMID 32881535 DOI: 10.1021/acs.molpharmaceut.0c00529   
2020 Permpoon U, Khan F, Vadevoo SMP, Gurung S, Gunassekaran GR, Kim MJ, Kim SH, Thuwajit P, Lee B. Inhibition of Tumor Growth against Chemoresistant Cholangiocarcinoma by a Pro-apoptotic Peptide Targeting Interleukin-4 Receptor. Molecular Pharmaceutics. PMID 32881535 DOI: 10.1021/acs.molpharmaceut.0c00529   
2020 Yilmaz E, Engin MN, Özkan ZG, Kovan B, Büyükkaya F, Poyanli A, Sağlam S, Başaran M, Türkmen C. Y90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not? Nuclear Medicine Communications. PMID 32941405 DOI: 10.1097/MNM.0000000000001284   
2020 Feng J, Xiao T, Lu SS, Hung XP, Yi H, He QY, Huang W, Tang YY, Xiao ZQ. ANXA1‑derived peptides suppress gastric and colon cancer cell growth by targeting EphA2 degradation. International Journal of Oncology. PMID 32901832 DOI: 10.3892/ijo.2020.5119   
2020 Zhao Z, Qiu K, Liu J, Hao X, Wang J. Two-photon photodynamic ablation of tumour cells using an RGD peptide-conjugated ruthenium(II) photosensitiser. Chemical Communications (Cambridge, England). PMID 32940288 DOI: 10.1039/d0cc04943c   
2020 Vatsa R, Madaan S, Chakraborty S, Dash A, Singh G, Mittal BR, Shukla J. Clinical evaluation of kit based Tc-99m-HYNIC-RGD2 for imaging angiogenesis in breast carcinoma patients. Nuclear Medicine Communications. PMID 32941401 DOI: 10.1097/MNM.0000000000001282   
2020 Hwang YJ, Myung H. Engineered Bacteriophage T7 as a Potent Anticancer Agent . Frontiers in Microbiology. 11: 491001. PMID 33072000 DOI: 10.3389/fmicb.2020.491001   
2020 Wang Q, Zhan Y, Ling S, Huang H, Zhang Y, Chen G, Huang S, Li C, Guo W. Rapid and Nondestructive Histopathological Analysis for Intraoperative Cancer Diagnosis Using an Enzyme-Activated NIR-II Nanoprobe. Angewandte Chemie (International Ed. in English). PMID 33015947 DOI: 10.1002/anie.202011903   
2020 Desai D, Shende P. Strategic aspects of NPY-based monoclonal antibodies for diagnosis and treatment of breast cancer. Current Protein & Peptide Science. PMID 32951575 DOI: 10.2174/1389203721666200918151604   
2020 Desai D, Shende P. Strategic aspects of NPY-based monoclonal antibodies for diagnosis and treatment of breast cancer. Current Protein & Peptide Science. PMID 32951575 DOI: 10.2174/1389203721666200918151604   
2020 Song S, Gui L, Feng Q, Taledaohan A, Li Y, Wang W, Wang Y, Wang Y. TAT-Modified Gold Nanoparticles Enhance the Antitumor Activity of PAD4 Inhibitors. International Journal of Nanomedicine. 15: 6659-6671. PMID 32982225 DOI: 10.2147/IJN.S255546   
2020 Lu X, Liang H, Orvig C, Chen ZF. Peptide and Small Molecule Inhibitors Targeting Myeloid Cell Leukemia 1 (Mcl-1) as Novel Antitumor Agents. Current Molecular Medicine. PMID 32990536 DOI: 10.2174/1566524020666200929121016   
2020 Lu X, Liang H, Orvig C, Chen ZF. Peptide and Small Molecule Inhibitors Targeting Myeloid Cell Leukemia 1 (Mcl-1) as Novel Antitumor Agents. Current Molecular Medicine. PMID 32990536 DOI: 10.2174/1566524020666200929121016   
2020 Cox D. How not to discover a drug - integrins. Expert Opinion On Drug Discovery. 1-15. PMID 32921156 DOI: 10.1080/17460441.2020.1819234   
2020 Chen X, Niu S, Bremner DH, Zhang X, Zhang H, Zhang Y, Li S, Zhu LM. Co-delivery of doxorubicin and oleanolic acid by triple-sensitive nanocomposite based on chitosan for effective promoting tumor apoptosis. Carbohydrate Polymers. 247: 116672. PMID 32829800 DOI: 10.1016/j.carbpol.2020.116672   
2020 Allen R, Ivtchenko E, Thuamsang B, Sangsuwan R, Lewis JS. Polymer-loaded hydrogels serve as depots for lactate and mimic "cold" tumor microenvironments. Biomaterials Science. PMID 33000781 DOI: 10.1039/d0bm01196g   
2020 Biteghe FAN, Mungra N, Chalomie NET, Ndong JC, Engohang-Ndong J, Vignaux G, Padayachee E, Naran K, Barth S. Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies. Oncotarget. 11: 3531-3557. PMID 33014289 DOI: 10.18632/oncotarget.27730   
2020 Ballhausen A, Przybilla MJ, Jendrusch M, Haupt S, Pfaffendorf E, Seidler F, Witt J, Hernandez Sanchez A, Urban K, Draxlbauer M, Krausert S, Ahadova A, Kalteis MS, Pfuderer PL, Heid D, et al. The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution. Nature Communications. 11: 4740. PMID 32958755 DOI: 10.1038/s41467-020-18514-5   
2020 Baindara P, Mandal SM. Bacteria and bacterial anticancer agents as a promising alternative for cancer therapeutics. Biochimie. 177: 164-189. PMID 32827604 DOI: 10.1016/j.biochi.2020.07.020   
2020 Yang P, Wang Y, Yao Z, Gao X, Liu C, Wang X, Wu H, Ding X, Hu J, Lin B, Li Q, Li M, Li X, Chen X, Qi W, et al. Enhanced safety and anti-tumor efficacy of switchable dual chimeric antigen receptor-engineered T cell against solid tumor through a synthetic bifunctional PD-L1-blocking peptide. Journal of the American Chemical Society. PMID 32966054 DOI: 10.1021/jacs.0c08538   
2020 Basso J, Mendes M, Silva J, Sereno J, Cova T, Oliveira R, Fortuna A, Castelo-Branco M, Falcão A, Sousa J, Pais A, Vitorino C. Peptide-lipid nanoconstructs act site-specifically towards glioblastoma growth impairment. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 32828948 DOI: 10.1016/j.ejpb.2020.08.015   
2020 Holmes TR, Al-Matouq J, Holmes M, Sioda N, Rudd JC, Bloom C, Nicola L, Palermo NY, Madson JG, Lovas S, Hansen LA. Targeting 14-3-3ε activates apoptotic signaling to prevent cutaneous squamous cell carcinoma. Carcinogenesis. PMID 32816038 DOI: 10.1093/carcin/bgaa091